pteridines has been researched along with Carcinoma, Ductal, Pancreatic in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Finally, pancreatic cancer cells expressing Plk1-unphosphorylatable mutants of Orc2 or Hbo1 are more sensitive to gemcitabine than cells expressing wild-type Orc2 or Hbo1." | 1.39 | Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancer. ( Chiorean, EG; Elzey, BD; Hazbun, T; Konieczny, SF; Kuang, S; Liu, X; Liu, XS; Ratliff, TL; Rice, SJ; Song, B, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaneda, MM | 1 |
| Cappello, P | 1 |
| Nguyen, AV | 1 |
| Ralainirina, N | 1 |
| Hardamon, CR | 1 |
| Foubert, P | 1 |
| Schmid, MC | 1 |
| Sun, P | 1 |
| Mose, E | 1 |
| Bouvet, M | 1 |
| Lowy, AM | 1 |
| Valasek, MA | 1 |
| Sasik, R | 1 |
| Novelli, F | 1 |
| Hirsch, E | 1 |
| Varner, JA | 1 |
| Song, B | 1 |
| Liu, XS | 1 |
| Rice, SJ | 1 |
| Kuang, S | 1 |
| Elzey, BD | 1 |
| Konieczny, SF | 1 |
| Ratliff, TL | 1 |
| Hazbun, T | 1 |
| Chiorean, EG | 1 |
| Liu, X | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase 2 Window of Opportunity Study of IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma[NCT03795610] | Phase 2 | 15 participants (Anticipated) | Interventional | 2020-03-06 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for pteridines and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression.
Topics: Animals; Antineoplastic Agents; Biomarkers; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Mov | 2016 |
Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Pancreatic Ductal; Cell Cycle Proteins; Cell Li | 2013 |